ERBB2 and breast cancer: Identification of tumors harboring amplifications is easier to be implemented in the clinical setting as has been the case in BC for HER2. Of note, many genes that are not frequently amplified but may have high expression rates and be of prognostic interest in BC are not discussed in our analysis.